IL295233A - Translation: diagnosis of congenital cytomegalovirus infection - Google Patents
Translation: diagnosis of congenital cytomegalovirus infectionInfo
- Publication number
- IL295233A IL295233A IL295233A IL29523322A IL295233A IL 295233 A IL295233 A IL 295233A IL 295233 A IL295233 A IL 295233A IL 29523322 A IL29523322 A IL 29523322A IL 295233 A IL295233 A IL 295233A
- Authority
- IL
- Israel
- Prior art keywords
- level
- ccmv
- biomarker
- symptomatic
- biological sample
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title claims description 29
- 206010010430 Congenital cytomegalovirus infection Diseases 0.000 title description 22
- 239000000090 biomarker Substances 0.000 claims description 375
- 239000012472 biological sample Substances 0.000 claims description 271
- 238000000034 method Methods 0.000 claims description 176
- 208000015181 infectious disease Diseases 0.000 claims description 152
- 102100040510 Galectin-3-binding protein Human genes 0.000 claims description 114
- 101000967904 Homo sapiens Galectin-3-binding protein Proteins 0.000 claims description 112
- 102100033914 Retinoic acid receptor responder protein 2 Human genes 0.000 claims description 109
- 210000003754 fetus Anatomy 0.000 claims description 106
- 241000701022 Cytomegalovirus Species 0.000 claims description 101
- 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 claims description 82
- 210000004381 amniotic fluid Anatomy 0.000 claims description 82
- 101000904724 Homo sapiens Transmembrane glycoprotein NMB Proteins 0.000 claims description 81
- 108090000623 proteins and genes Proteins 0.000 claims description 64
- 102000004169 proteins and genes Human genes 0.000 claims description 58
- 206010010356 Congenital anomaly Diseases 0.000 claims description 55
- -1 MYTH4 Proteins 0.000 claims description 55
- 102100020867 Secretogranin-1 Human genes 0.000 claims description 46
- 101710085819 Angiopoietin-related protein 6 Proteins 0.000 claims description 45
- 102100034599 Angiopoietin-related protein 6 Human genes 0.000 claims description 45
- 108090000007 Carboxypeptidase M Proteins 0.000 claims description 44
- 102100032936 Carboxypeptidase M Human genes 0.000 claims description 44
- 102100023306 Nesprin-1 Human genes 0.000 claims description 44
- 102100036683 Growth arrest-specific protein 1 Human genes 0.000 claims description 42
- 101000716809 Homo sapiens Secretogranin-1 Proteins 0.000 claims description 41
- 108010080937 Carboxypeptidases A Proteins 0.000 claims description 40
- 102000000496 Carboxypeptidases A Human genes 0.000 claims description 40
- 101710135446 Growth arrest-specific protein 1 Proteins 0.000 claims description 39
- 101000624947 Homo sapiens Nesprin-1 Proteins 0.000 claims description 39
- 102100037269 Secretoglobin family 3A member 2 Human genes 0.000 claims description 39
- 101710176359 Secretoglobin family 3A member 2 Proteins 0.000 claims description 39
- 101710164680 Platelet-derived growth factor receptor beta Proteins 0.000 claims description 38
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 claims description 38
- 102100033582 Dermokine Human genes 0.000 claims description 37
- 101710130746 Dermokine Proteins 0.000 claims description 37
- 102100032972 Myosin-14 Human genes 0.000 claims description 37
- 102100036154 Platelet basic protein Human genes 0.000 claims description 37
- 101000588964 Homo sapiens Myosin-14 Proteins 0.000 claims description 32
- 238000011282 treatment Methods 0.000 claims description 32
- 101000958744 Homo sapiens Myosin-7B Proteins 0.000 claims description 31
- 230000035935 pregnancy Effects 0.000 claims description 28
- 210000002966 serum Anatomy 0.000 claims description 25
- 210000004369 blood Anatomy 0.000 claims description 20
- 239000008280 blood Substances 0.000 claims description 20
- 239000000523 sample Substances 0.000 claims description 19
- 238000003556 assay Methods 0.000 claims description 17
- 230000008774 maternal effect Effects 0.000 claims description 17
- 210000004700 fetal blood Anatomy 0.000 claims description 16
- 238000002965 ELISA Methods 0.000 claims description 14
- 101001132652 Homo sapiens Retinoic acid receptor responder protein 2 Proteins 0.000 claims description 14
- 230000008859 change Effects 0.000 claims description 13
- 230000002265 prevention Effects 0.000 claims description 11
- 238000001514 detection method Methods 0.000 claims description 9
- 238000008157 ELISA kit Methods 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 102100024361 Disintegrin and metalloproteinase domain-containing protein 9 Human genes 0.000 claims description 7
- 238000001574 biopsy Methods 0.000 claims description 7
- 210000002381 plasma Anatomy 0.000 claims description 7
- 238000002560 therapeutic procedure Methods 0.000 claims description 7
- 210000003954 umbilical cord Anatomy 0.000 claims description 7
- 238000012544 monitoring process Methods 0.000 claims description 6
- 230000003169 placental effect Effects 0.000 claims description 6
- 238000005070 sampling Methods 0.000 claims description 6
- 101710115136 Myosin-14 Proteins 0.000 claims description 5
- 101710202335 Nesprin-1 Proteins 0.000 claims description 5
- 102000015795 Platelet Membrane Glycoproteins Human genes 0.000 claims description 5
- 108010010336 Platelet Membrane Glycoproteins Proteins 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims description 5
- 238000005259 measurement Methods 0.000 claims description 5
- 101710192385 Secretogranin-1 Proteins 0.000 claims description 4
- 238000004949 mass spectrometry Methods 0.000 claims description 4
- 101000832769 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 9 Proteins 0.000 claims 4
- 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 claims 4
- KMGARVOVYXNAOF-UHFFFAOYSA-N benzpiperylone Chemical compound C1CN(C)CCC1N1C(=O)C(CC=2C=CC=CC=2)=C(C=2C=CC=CC=2)N1 KMGARVOVYXNAOF-UHFFFAOYSA-N 0.000 claims 4
- 101001072723 Homo sapiens Growth arrest-specific protein 1 Proteins 0.000 claims 3
- 101710170513 Retinoic acid receptor responder protein 2 Proteins 0.000 description 97
- 235000018102 proteins Nutrition 0.000 description 55
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 31
- 201000010099 disease Diseases 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 17
- 230000035945 sensitivity Effects 0.000 description 13
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 12
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 12
- 230000001605 fetal effect Effects 0.000 description 12
- 102100036774 Afamin Human genes 0.000 description 11
- 101710149366 Afamin Proteins 0.000 description 11
- 102100024153 Cadherin-15 Human genes 0.000 description 11
- 102100035037 Calpastatin Human genes 0.000 description 11
- 101710126238 Collagen alpha-2(I) chain Proteins 0.000 description 11
- 102100036213 Collagen alpha-2(I) chain Human genes 0.000 description 11
- 101000775053 Homo sapiens Neuroblast differentiation-associated protein AHNAK Proteins 0.000 description 11
- 102000000299 Latrophilin-2 Human genes 0.000 description 11
- 108050008761 Latrophilin-2 Proteins 0.000 description 11
- 101710158772 Lipolysis-stimulated lipoprotein receptor Proteins 0.000 description 11
- 102100032010 Lipolysis-stimulated lipoprotein receptor Human genes 0.000 description 11
- 108010018562 M-cadherin Proteins 0.000 description 11
- 102100038990 Multiple epidermal growth factor-like domains protein 8 Human genes 0.000 description 11
- 101710101932 Multiple epidermal growth factor-like domains protein 8 Proteins 0.000 description 11
- 102100031837 Neuroblast differentiation-associated protein AHNAK Human genes 0.000 description 11
- 108091009503 Pappalysin-2 Proteins 0.000 description 11
- 102100034869 Plasma kallikrein Human genes 0.000 description 11
- 102100020950 Polypeptide N-acetylgalactosaminyltransferase 2 Human genes 0.000 description 11
- 102100029500 Prostasin Human genes 0.000 description 11
- 102100022127 Radixin Human genes 0.000 description 11
- 102100034371 Sulfhydryl oxidase 1 Human genes 0.000 description 11
- 102100020889 Suprabasin Human genes 0.000 description 11
- 101710134372 Suprabasin Proteins 0.000 description 11
- 102100033740 Tenomodulin Human genes 0.000 description 11
- 101710114852 Tenomodulin Proteins 0.000 description 11
- 108010044208 calpastatin Proteins 0.000 description 11
- 108010031970 prostasin Proteins 0.000 description 11
- 108010048484 radixin Proteins 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 206010011831 Cytomegalovirus infection Diseases 0.000 description 10
- 102100038285 Endogenous retroviral envelope protein HEMO Human genes 0.000 description 10
- 101001033183 Homo sapiens Endogenous retroviral envelope protein HEMO Proteins 0.000 description 10
- 102000004371 Insulin-like growth factor binding protein 5 Human genes 0.000 description 10
- 108090000961 Insulin-like growth factor binding protein 5 Proteins 0.000 description 10
- 101710116771 Lysosome-associated membrane glycoprotein 2 Proteins 0.000 description 10
- 102100038225 Lysosome-associated membrane glycoprotein 2 Human genes 0.000 description 10
- 102100039679 N-acetylgalactosaminyltransferase 7 Human genes 0.000 description 10
- 102000033039 Pappalysin-2 Human genes 0.000 description 10
- 102000015736 beta 2-Microglobulin Human genes 0.000 description 10
- 108010081355 beta 2-Microglobulin Proteins 0.000 description 10
- ZXJCOYBPXOBJMU-HSQGJUDPSA-N calpastatin peptide Ac 184-210 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(O)=O)NC(C)=O)[C@@H](C)O)C1=CC=C(O)C=C1 ZXJCOYBPXOBJMU-HSQGJUDPSA-N 0.000 description 10
- 102100022890 ATP synthase subunit beta, mitochondrial Human genes 0.000 description 9
- 101710134855 ATP synthase subunit beta, mitochondrial Proteins 0.000 description 9
- 102100036608 Aspartate aminotransferase, cytoplasmic Human genes 0.000 description 9
- 102100037086 Bone marrow stromal antigen 2 Human genes 0.000 description 9
- 102100024650 Carbonic anhydrase 3 Human genes 0.000 description 9
- 101710167915 Carbonic anhydrase 3 Proteins 0.000 description 9
- 102000004225 Cathepsin B Human genes 0.000 description 9
- 108090000712 Cathepsin B Proteins 0.000 description 9
- 102100031552 Coactosin-like protein Human genes 0.000 description 9
- 101710105549 Coactosin-like protein Proteins 0.000 description 9
- 102100036912 Desmin Human genes 0.000 description 9
- 108010044052 Desmin Proteins 0.000 description 9
- 102000027313 Epiphycan Human genes 0.000 description 9
- 108091013881 Epiphycan Proteins 0.000 description 9
- 102100037738 Fatty acid-binding protein, heart Human genes 0.000 description 9
- 101710136552 Fatty acid-binding protein, heart Proteins 0.000 description 9
- 102100025656 Keratin, type II cytoskeletal 6A Human genes 0.000 description 9
- 101710083633 Keratin, type II cytoskeletal 6A Proteins 0.000 description 9
- 102100032421 Protein S100-A6 Human genes 0.000 description 9
- 108010005260 S100 Calcium Binding Protein A6 Proteins 0.000 description 9
- 101710135940 SH3 domain-binding glutamic acid-rich-like protein Proteins 0.000 description 9
- 102100024243 SH3 domain-binding glutamic acid-rich-like protein Human genes 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 210000005045 desmin Anatomy 0.000 description 9
- 239000003550 marker Substances 0.000 description 9
- 101150079978 AGRN gene Proteins 0.000 description 8
- 102100040026 Agrin Human genes 0.000 description 8
- 108700019743 Agrin Proteins 0.000 description 8
- 108010051118 Bone Marrow Stromal Antigen 2 Proteins 0.000 description 8
- 102100026679 Carboxypeptidase Q Human genes 0.000 description 8
- 101710093167 Carboxypeptidase Q Proteins 0.000 description 8
- 235000008474 Cardamine pratensis Nutrition 0.000 description 8
- 240000000606 Cardamine pratensis Species 0.000 description 8
- 101710196749 Cartilage acidic protein 1 Proteins 0.000 description 8
- 102100037988 Cartilage acidic protein 1 Human genes 0.000 description 8
- 101001091365 Homo sapiens Plasma kallikrein Proteins 0.000 description 8
- 101001002235 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 2 Proteins 0.000 description 8
- 101001131204 Homo sapiens Sulfhydryl oxidase 1 Proteins 0.000 description 8
- 108010067787 Proteoglycans Proteins 0.000 description 8
- 102000016611 Proteoglycans Human genes 0.000 description 8
- 108010026552 Proteome Proteins 0.000 description 8
- 102100021853 Secreted and transmembrane protein 1 Human genes 0.000 description 8
- 101710126682 Secreted and transmembrane protein 1 Proteins 0.000 description 8
- 102100038836 Superoxide dismutase [Cu-Zn] Human genes 0.000 description 8
- 101710139715 Superoxide dismutase [Cu-Zn] Proteins 0.000 description 8
- 208000035475 disorder Diseases 0.000 description 8
- 102100030074 Dickkopf-related protein 1 Human genes 0.000 description 7
- 101710099518 Dickkopf-related protein 1 Proteins 0.000 description 7
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 101000929698 Homo sapiens Aspartate aminotransferase, cytoplasmic Proteins 0.000 description 6
- 101000904228 Homo sapiens Vesicle transport protein GOT1A Proteins 0.000 description 6
- 101000904204 Homo sapiens Vesicle transport protein GOT1B Proteins 0.000 description 6
- 101710117390 Mannan-binding lectin serine protease 1 Proteins 0.000 description 6
- 102100026061 Mannan-binding lectin serine protease 1 Human genes 0.000 description 6
- 238000003018 immunoassay Methods 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 206010011891 Deafness neurosensory Diseases 0.000 description 5
- 101000709256 Homo sapiens Signal-regulatory protein beta-1 Proteins 0.000 description 5
- 101000709188 Homo sapiens Signal-regulatory protein beta-1 isoform 3 Proteins 0.000 description 5
- 101000622304 Homo sapiens Vascular cell adhesion protein 1 Proteins 0.000 description 5
- 208000009966 Sensorineural Hearing Loss Diseases 0.000 description 5
- 102100032770 Signal-regulatory protein beta-1 isoform 3 Human genes 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 238000003793 prenatal diagnosis Methods 0.000 description 5
- 231100000879 sensorineural hearing loss Toxicity 0.000 description 5
- 208000023573 sensorineural hearing loss disease Diseases 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- 238000010200 validation analysis Methods 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 238000012286 ELISA Assay Methods 0.000 description 4
- 208000022471 Fetal disease Diseases 0.000 description 4
- 101710195957 Platelet basic protein Proteins 0.000 description 4
- 102100034547 Protocadherin Fat 4 Human genes 0.000 description 4
- 101710095094 Protocadherin Fat 4 Proteins 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 238000003368 label free method Methods 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 102100037529 Coagulation factor V Human genes 0.000 description 3
- 108010026759 Cytoplasmic Aspartate Aminotransferase Proteins 0.000 description 3
- 101710116121 Disintegrin and metalloproteinase domain-containing protein 9 Proteins 0.000 description 3
- 102000057728 Extracellular superoxide dismutase [Cu-Zn] Human genes 0.000 description 3
- 108700001268 Extracellular superoxide dismutase [Cu-Zn] Proteins 0.000 description 3
- 108010014172 Factor V Proteins 0.000 description 3
- 208000001362 Fetal Growth Retardation Diseases 0.000 description 3
- 101710197901 Galectin-3-binding protein Proteins 0.000 description 3
- 102100027450 Laminin subunit alpha-5 Human genes 0.000 description 3
- 101710200521 Laminin subunit alpha-5 Proteins 0.000 description 3
- 108090000113 Plasma Kallikrein Proteins 0.000 description 3
- 108010066816 Polypeptide N-acetylgalactosaminyltransferase Proteins 0.000 description 3
- 102000005806 Serine Peptidase Inhibitor Kazal-Type 5 Human genes 0.000 description 3
- 108010005020 Serine Peptidase Inhibitor Kazal-Type 5 Proteins 0.000 description 3
- 101710159725 Sulfhydryl oxidase 1 Proteins 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 208000030941 fetal growth restriction Diseases 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000004393 prognosis Methods 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 108090000064 retinoic acid receptors Proteins 0.000 description 3
- 102000003702 retinoic acid receptors Human genes 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 102100035337 Bone marrow proteoglycan Human genes 0.000 description 2
- 101710134771 Bone marrow proteoglycan Proteins 0.000 description 2
- 206010062343 Congenital infection Diseases 0.000 description 2
- 238000009007 Diagnostic Kit Methods 0.000 description 2
- 101800001224 Disintegrin Proteins 0.000 description 2
- 102000000802 Galectin 3 Human genes 0.000 description 2
- 108010001517 Galectin 3 Proteins 0.000 description 2
- 102100028971 HLA class I histocompatibility antigen, C alpha chain Human genes 0.000 description 2
- 101000986084 Homo sapiens HLA class I histocompatibility antigen, C alpha chain Proteins 0.000 description 2
- 241000701024 Human betaherpesvirus 5 Species 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 102000009112 Mannose-Binding Lectin Human genes 0.000 description 2
- 108010087870 Mannose-Binding Lectin Proteins 0.000 description 2
- 102000005741 Metalloproteases Human genes 0.000 description 2
- 108010006035 Metalloproteases Proteins 0.000 description 2
- 101710123311 N-acetylgalactosaminyltransferase 7 Proteins 0.000 description 2
- 101100194363 Schizosaccharomyces pombe (strain 972 / ATCC 24843) res2 gene Proteins 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 101710170091 Transmembrane glycoprotein NMB Proteins 0.000 description 2
- HDOVUKNUBWVHOX-QMMMGPOBSA-N Valacyclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCOC(=O)[C@@H](N)C(C)C)C=N2 HDOVUKNUBWVHOX-QMMMGPOBSA-N 0.000 description 2
- 101710160666 Vascular cell adhesion protein 1 Proteins 0.000 description 2
- 238000002669 amniocentesis Methods 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 102000048013 human RARRES2 Human genes 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000001123 neurodevelopmental effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 229940093257 valacyclovir Drugs 0.000 description 2
- 241000372033 Andromeda Species 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 208000004434 Calcinosis Diseases 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 101000926196 Cercopithecine herpesvirus 9 (strain DHV) Envelope glycoprotein E Proteins 0.000 description 1
- 108010038439 Chromogranin B Proteins 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 208000027205 Congenital disease Diseases 0.000 description 1
- 229910017518 Cu Zn Inorganic materials 0.000 description 1
- 229910017752 Cu-Zn Inorganic materials 0.000 description 1
- 241000724252 Cucumber mosaic virus Species 0.000 description 1
- 229910017943 Cu—Zn Inorganic materials 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 108010003471 Fetal Proteins Proteins 0.000 description 1
- 102000004641 Fetal Proteins Human genes 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 1
- 108010024164 HLA-G Antigens Proteins 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000621344 Homo sapiens Protein Wnt-2 Proteins 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010021882 Infections and infestations congenital Diseases 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 208000035752 Live birth Diseases 0.000 description 1
- 102000009565 Lysosomal-Associated Membrane Protein 2 Human genes 0.000 description 1
- 108010009491 Lysosomal-Associated Membrane Protein 2 Proteins 0.000 description 1
- 101900253558 Mannan-binding lectin serine protease 1 (isoform 1) Proteins 0.000 description 1
- 208000020241 Neonatal disease Diseases 0.000 description 1
- 208000037129 Newborn Diseases Infant Diseases 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 108010076039 Polyproteins Proteins 0.000 description 1
- 101710180319 Protease 1 Proteins 0.000 description 1
- 102100022805 Protein Wnt-2 Human genes 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 101000652341 Rarobacter faecitabidus Serine protease 1 Proteins 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 102000000395 SH3 domains Human genes 0.000 description 1
- 108050008861 SH3 domains Proteins 0.000 description 1
- 101100255212 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rsa3 gene Proteins 0.000 description 1
- 102000011274 Secretoglobin Human genes 0.000 description 1
- 108050001520 Secretoglobin Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229940122055 Serine protease inhibitor Drugs 0.000 description 1
- 101710102218 Serine protease inhibitor Proteins 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 101710137710 Thioesterase 1/protease 1/lysophospholipase L1 Proteins 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000007962 Type II Keratins Human genes 0.000 description 1
- 108010089374 Type II Keratins Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000007698 birth defect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 238000007623 carbamidomethylation reaction Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 208000015278 cerebellar malformation Diseases 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 201000004709 chorioretinitis Diseases 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- TVZPLCNGKSPOJA-UHFFFAOYSA-N copper zinc Chemical compound [Cu].[Zn] TVZPLCNGKSPOJA-UHFFFAOYSA-N 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 230000003436 cytoskeletal effect Effects 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006240 deamidation Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 231100000562 fetal loss Toxicity 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 231100000888 hearing loss Toxicity 0.000 description 1
- 230000010370 hearing loss Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000000521 hyperimmunizing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- FWYSMLBETOMXAG-QHCPKHFHSA-N letermovir Chemical compound COC1=CC=CC(N2CCN(CC2)C=2N([C@@H](CC(O)=O)C3=CC=CC(F)=C3N=2)C=2C(=CC=C(C=2)C(F)(F)F)OC)=C1 FWYSMLBETOMXAG-QHCPKHFHSA-N 0.000 description 1
- 229950010668 letermovir Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 208000004141 microcephaly Diseases 0.000 description 1
- 238000007392 microtiter assay Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 108091005601 modified peptides Proteins 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000010844 nanoflow liquid chromatography Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000092 prognostic biomarker Substances 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 238000011309 routine diagnosis Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003001 serine protease inhibitor Substances 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000011311 validation assay Methods 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Steam Or Hot-Water Central Heating Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062969176P | 2020-02-03 | 2020-02-03 | |
| PCT/IL2021/050125 WO2021156860A1 (en) | 2020-02-03 | 2021-02-03 | Diagnosis of congenital cytomegalovirus infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL295233A true IL295233A (en) | 2022-10-01 |
Family
ID=77199756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL295233A IL295233A (en) | 2020-02-03 | 2021-02-03 | Translation: diagnosis of congenital cytomegalovirus infection |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4100744A4 (de) |
| AU (1) | AU2021217240A1 (de) |
| CA (1) | CA3169402A1 (de) |
| IL (1) | IL295233A (de) |
| WO (1) | WO2021156860A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12504429B2 (en) | 2020-02-03 | 2025-12-23 | Hadasit Medical Research Services And Development Ltd. | Diagnosis of congenital cytomegalovirus infection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2212693B1 (de) * | 2007-10-22 | 2015-04-22 | The Regents of The University of California | Biomarker für die pränatale diagnose |
| WO2010144358A1 (en) * | 2009-06-08 | 2010-12-16 | Singulex, Inc. | Highly sensitive biomarker panels |
| US20140186332A1 (en) * | 2012-12-28 | 2014-07-03 | NX Pharmagen | Biomarkers of preterm birth |
-
2021
- 2021-02-03 CA CA3169402A patent/CA3169402A1/en active Pending
- 2021-02-03 IL IL295233A patent/IL295233A/en unknown
- 2021-02-03 WO PCT/IL2021/050125 patent/WO2021156860A1/en not_active Ceased
- 2021-02-03 EP EP21750486.9A patent/EP4100744A4/de active Pending
- 2021-02-03 AU AU2021217240A patent/AU2021217240A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021217240A1 (en) | 2022-09-22 |
| CA3169402A1 (en) | 2021-08-12 |
| EP4100744A1 (de) | 2022-12-14 |
| EP4100744A4 (de) | 2024-07-24 |
| WO2021156860A1 (en) | 2021-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bravo-Miana et al. | Central nervous system-derived extracellular vesicles: the next generation of neural circulating biomarkers? | |
| EP3514245B1 (de) | Verfahren zur unterstützung der differentiellen diagnose eines schlaganfalls | |
| Bolatkale et al. | A novel biochemical marker for community-acquired pneumonia: Ischemia-modified albumin | |
| Vorontsov et al. | Amniotic fluid biomarkers predict the severity of congenital cytomegalovirus infection | |
| AU2012343537B2 (en) | Biomarker-based methods and biochips for aiding the diagnosis of stroke | |
| IL298100A (en) | Protein markers for assessing alzheimer's disease | |
| El-Asrar et al. | Fatty acid binding protein 1 (FABP1) and fatty acid binding protein 2 (FABP2) as a link between diabetic nephropathy and subclinical atherosclerosis in children and adolescents with type 1 diabetes | |
| IL295233A (en) | Translation: diagnosis of congenital cytomegalovirus infection | |
| US20150160240A1 (en) | Host Biomarkers for Dengue Fever (DF) and Methods Thereof | |
| US12504429B2 (en) | Diagnosis of congenital cytomegalovirus infection | |
| Wang et al. | Expression and significance of interleukin-17 and interleukin-22 in the serum and the lower esophageal sphincter of patients with achalasia | |
| US20130337476A1 (en) | URINARY sCD14 AS A BIOMARKER FOR CORONARY ARTERY DISEASE | |
| US8048639B2 (en) | Method for evaluating risk in multiple sclerosis | |
| Kumar et al. | Patterns of Liver Injury and Adaptation in Patients With Abdominal Tuberculosis on Antituberculosis Treatment: A Prospective Cohort Study | |
| WO2023068081A1 (ja) | 好酸球性中耳炎、好酸球性副鼻腔炎、好酸球性多発血管炎性肉芽腫症のうち少なくとも１種以上であると診断、診断補助、判定及び判定補助の１以上をするためのバイオマーカー、そのための方法ならびにキット | |
| JP7062063B2 (ja) | 前立腺がんに特異的な糖鎖、及びこれを用いた検査方法 | |
| Demir et al. | The role of aspartate aminotransferase/platelet ratio index score in predicting intrahepatic cholestasis of pregnancy and its relationship with total bile acid level: A Case-Control study from a tertiary center | |
| US20110117583A1 (en) | Method for detecting the existence of renal calculi and/or inflammation of the excretory urinary tracts | |
| Grigoli et al. | Diagnostic value of C-Reactive Protein, Albumin, and the CRP-to-Albumin ratio for predicting mortality in hospitalized patients with COVID-19 in Brazilian hospitals | |
| US20250012816A1 (en) | Method and kit for diagnosing alzheimer's disease based on the detection of apolipoprotein e | |
| Jing et al. | Plasma p-tau217, p-tau181 and Aβ42/40 for Alzheimer’s disease diagnosis: ROC accuracy and 18F-florbetapir amyloid PET-CT concordance | |
| He et al. | Diagnostic performance of plasma p-tau217 levels measured with different assays for Alzheimer’s disease | |
| IL323886A (en) | Protein markers for mild cognitive impairment and alzheimer's disease | |
| HK40127144A (zh) | 轻度认知障碍和阿尔茨海默氏病的蛋白标志物 | |
| Reddy | A Study On Non Invasive Predictors Of Large Esophageal Varices In Paitents With Cirrhosis |